OBJECTIVE
To determine in presymptomatic individuals who carry the gene mutation for Huntington disease whether proximity to estimated age at onset is associated with volume of basal ganglia, as measured on magnetic resonance imaging scans.
DESIGN
Survey study involving correlations between basal ganglia volume, measured blind to subject status, and estimation of subjects' age at onset.
SETTING
Huntington's Disease Presymptomatic Testing Program at The Johns Hopkins University School of Medicine, Baltimore, Md.
PATIENTS AND OTHER PARTICIPANTS
Subjects included 47 individuals at risk for Huntington disease (ie, off-spring of patients with Huntington disease). Twenty subjects tested positive for the gene mutation but were not symptomatic. Twenty-seven subjects tested negative.
MAIN OUTCOME MEASURES
Estimated age at onset was calculated for each of 20 gene-positive individuals using an empirically derived formula based on the subject's trinucleotide repeat length and parental age at onset. Each subject's age at the time of the magnetic resonance imaging scan was subtracted from his or her estimated age at onset, yielding estimated years to onset. Volumes of caudate, putamen, and globus pallidus were measured on magnetic resonance imaging scans.
RESULTS
After controlling for the subject's age at the time of the scan, significant correlations were found between volumes of all basal ganglia structures and years to onset. Gene-positive subjects who were far from onset had smaller basal ganglia volumes than gene-negative subjects for all structures except globus pallidus. Gene-positive subjects who were close to onset had smaller volumes than gene-negative subjects for all basal ganglia structures and had smaller volumes than subjects far from onset for all structures except caudate.
CONCLUSIONS
The results suggest that atrophy of the basal ganglia occurs gradually, beginning years before symptom onset.
[1]
J. Brandt,et al.
Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk persons
,
1994,
Neurology.
[2]
Manish S. Shah,et al.
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
,
1993,
Cell.
[3]
S. Folstein,et al.
Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease
,
1992,
Annals of neurology.
[4]
A. Poustka,et al.
Recombination events suggest potential sites for the Huntington's disease gene
,
1989,
Neuron.
[5]
L. Carrasco,et al.
ATROPHY OF CORPUS STRIATUM IN NORMAL MALE AT RISK OF HUNTINGTON'S CHOREA
,
1986,
The Lancet.
[6]
R. Ferrante,et al.
Neuropathological Classification of Huntington's Disease
,
1985,
Journal of neuropathology and experimental neurology.
[7]
A. Young,et al.
A polymorphic DNA marker genetically linked to Huntington's disease
,
1983,
Nature.
[8]
R J Leigh,et al.
The measurement of abnormal movement: methods developed for Huntington's disease.
,
1983,
Neurobehavioral toxicology and teratology.